Publishing research using ab101500? Please let us know so that we can cite the reference in this datasheet.

ab101500 has been referenced in 9 publications.

  • Fisher TS  et al. A CD3-bispecific molecule targeting P-cadherin demonstrates T cell-mediated regression of established solid tumors in mice. Cancer Immunol Immunother 67:247-259 (2018). PubMed: 29067496
  • Uryvaev A  et al. The role of tumor-infiltrating lymphocytes (TILs) as a predictive biomarker of response to anti-PD1 therapy in patients with metastatic non-small cell lung cancer or metastatic melanoma. Med Oncol 35:25 (2018). PubMed: 29388007
  • Leduc C  et al. TPF induction chemotherapy increases PD-L1 expression in tumour cells and immune cells in head and neck squamous cell carcinoma. ESMO Open 3:e000257 (2018). PubMed: 29344407
  • Li W  et al. Systemic HIV-1 infection produces a unique glial footprint in humanized mouse brains. Dis Model Mech 10:1489-1502 (2017). PubMed: 29084769
  • Gong Y  et al. Cytoplasmic expression of C-MYC protein is associated with risk stratification of mantle cell lymphoma. PeerJ 5:e3457 (2017). IHC-P ; Human . PubMed: 28626618
  • Verbiest A  et al. Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated With Outcome During Pazopanib Therapy in the Metastatic Setting. Clin Genitourin Cancer N/A:N/A (2017). PubMed: 29239846
  • Fucikova J  et al. Calreticulin Expression in Human Non-Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis. Cancer Res 76:1746-56 (2016). PubMed: 26842877
  • Dai Z  et al. CXCR3 Blockade Inhibits T Cell Migration into the Skin and Prevents Development of Alopecia Areata. J Immunol 197:1089-99 (2016). PubMed: 27412416
  • Wick DA  et al. Surveillance of the tumor mutanome by T cells during progression from primary to recurrent ovarian cancer. Clin Cancer Res 20:1125-34 (2014). PubMed: 24323902

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up